US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.

Hiruy H, Bala S, Byrne JM, Roche KG, Jang SH, Kim P, Nambiar S, Rubin D, Yasinskaya Y, Bachmann LH, Bernstein K, Botgros R, Cammarata S, Chaves RL, Deal CD, Drusano GL, Duffy EM, Eakin AE, Gelone S, Hiltke T, Hook EW 3rd, Jerse AE, McNeil CJ, Newman L, O'Brien S, Perry C, Reno HEL, Romaguera RA, Sato J, Unemo M, Wi TEC, Workowski K, O'May GA, Shukla SJ, Farley JJ

Open source

DOI
10.1093/cid/ciae386
Published
2026 Feb 4
Container
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciae386,
  title = {US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.},
  author = {Hiruy H and Bala S and Byrne JM and Roche KG and Jang SH and Kim P and Nambiar S and Rubin D and Yasinskaya Y and Bachmann LH and Bernstein K and Botgros R and Cammarata S and Chaves RL and Deal CD and Drusano GL and Duffy EM and Eakin AE and Gelone S and Hiltke T and Hook EW 3rd and Jerse AE and McNeil CJ and Newman L and O'Brien S and Perry C and Reno HEL and Romaguera RA and Sato J and Unemo M and Wi TEC and Workowski K and O'May GA and Shukla SJ and Farley JJ},
  year = {2026},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciae386},
  url = {https://doi.org/10.1093/cid/ciae386}
}

RIS

TY  - JOUR
TI  - US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
AU  - Hiruy H
AU  - Bala S
AU  - Byrne JM
AU  - Roche KG
AU  - Jang SH
AU  - Kim P
AU  - Nambiar S
AU  - Rubin D
AU  - Yasinskaya Y
AU  - Bachmann LH
AU  - Bernstein K
AU  - Botgros R
AU  - Cammarata S
AU  - Chaves RL
AU  - Deal CD
AU  - Drusano GL
AU  - Duffy EM
AU  - Eakin AE
AU  - Gelone S
AU  - Hiltke T
AU  - Hook EW 3rd
AU  - Jerse AE
AU  - McNeil CJ
AU  - Newman L
AU  - O'Brien S
AU  - Perry C
AU  - Reno HEL
AU  - Romaguera RA
AU  - Sato J
AU  - Unemo M
AU  - Wi TEC
AU  - Workowski K
AU  - O'May GA
AU  - Shukla SJ
AU  - Farley JJ
PY  - 2026
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciae386
UR  - https://doi.org/10.1093/cid/ciae386
ER  -

APA

H, H., S, B., JM, B., KG, R., SH, J., P, K., S, N., D, R., Y, Y., LH, B., K, B., R, B., S, C., RL, C., CD, D., GL, D., EM, D., AE, E., S, G., T, H., 3rd, H. E., AE, J., CJ, M., L, N., S, O., C, P., HEL, R., RA, R., J, S., M, U., TEC, W., K, W., GA, O., SJ, S., & JJ, F. (2026). US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciae386

Source records